X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (87) 87
humans (86) 86
index medicus (75) 75
acute coronary syndromes (59) 59
male (59) 59
female (58) 58
middle aged (51) 51
aged (49) 49
heart attacks (45) 45
coronary heart disease (43) 43
cardiovascular (40) 40
medical and health sciences (40) 40
medicin och hälsovetenskap (40) 40
abridged index medicus (37) 37
clopidogrel (36) 36
myocardial infarction (33) 33
mortality (32) 32
acute coronary syndrome - drug therapy (30) 30
treatment outcome (29) 29
clinical medicine (28) 28
klinisk medicin (27) 27
platelet aggregation inhibitors - therapeutic use (27) 27
acute coronary syndrome (26) 26
cardiac and cardiovascular systems (26) 26
double-blind method (26) 26
kardiologi (26) 26
cardiology (24) 24
follow-up studies (24) 24
care and treatment (23) 23
clinical trials (22) 22
risk factors (22) 22
myocardial-infarction (20) 20
thrombin (20) 20
analysis (19) 19
internal medicine (19) 19
outcomes (19) 19
vorapaxar (19) 19
cardiac patients (18) 18
drug therapy (18) 18
electrocardiography (18) 18
ischemia (18) 18
peripheral vascular disease (18) 18
risk (18) 18
acute coronary syndrome - mortality (17) 17
aspirin (17) 17
cardiovascular disease (17) 17
coronary vessels (17) 17
acute coronary syndrome - therapy (16) 16
platelet aggregation inhibitors - adverse effects (16) 16
tracers (16) 16
acute myocardial-infarction (15) 15
pyridines - therapeutic use (15) 15
stroke (15) 15
unstable angina (15) 15
acute coronary syndrome - complications (14) 14
heart attack (14) 14
percutaneous coronary intervention (14) 14
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (14) 14
acute coronary syndrome - diagnosis (13) 13
association (13) 13
cardiovascular diseases (13) 13
intervention (13) 13
lactones - therapeutic use (13) 13
medicine, general & internal (13) 13
st-segment elevation (13) 13
patient outcomes (12) 12
patients (12) 12
platelet aggregation inhibitors - administration & dosage (12) 12
bleeding (11) 11
drug therapy, combination (11) 11
lactones - administration & dosage (11) 11
myocardial infarction - drug therapy (11) 11
pyridines - administration & dosage (11) 11
thrombosis (11) 11
ticagrelor (11) 11
ticlopidine - analogs & derivatives (11) 11
time factors (11) 11
atherosclerosis (10) 10
diabetes (10) 10
health risk assessment (10) 10
hemorrhage - chemically induced (10) 10
incidence (10) 10
randomized controlled trials as topic (10) 10
receptor, par-1 - antagonists & inhibitors (10) 10
trial (10) 10
acute coronary syndrome - physiopathology (9) 9
adult (9) 9
cerebral infarction (9) 9
coronary artery bypass (9) 9
infarction (9) 9
lactones - adverse effects (9) 9
management (9) 9
platelets (9) 9
prasugrel (9) 9
pyridines - adverse effects (9) 9
studies (9) 9
acute coronary syndrome - surgery (8) 8
angina pectoris (8) 8
angioplasty (8) 8
cholesterol (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 682 - 689.e1
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 20 - 33
In this trial, vorapaxar, a protease-activated–receptor 1 antagonist that inhibits thrombin-induced platelet activation, was not effective in reducing the... 
MEDICINE, GENERAL & INTERNAL | PLACEBO | GLYCOPROTEIN IIB/IIIA INHIBITORS | CLOPIDOGREL | TASK-FORCE | SAFETY | DOUBLE-BLIND | ANTIPLATELET THERAPY | Follow-Up Studies | Angioplasty | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Combined Modality Therapy | Lactones - adverse effects | Lactones - therapeutic use | Acute Coronary Syndrome - drug therapy | Intracranial Hemorrhages - chemically induced | Coronary Artery Bypass | Acute Coronary Syndrome - therapy | Aged | Hemorrhage - chemically induced | Antagonists (Biochemistry) | Drugs | Dose-response relationship (Biochemistry) | Dosage and administration | Product/Service Evaluations | Drug therapy | Coronary heart disease | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Cardiovascular disease | Hemorrhage | Bleeding | Investigations | Manuscripts | Ischemia | Blood platelets | Acute coronary syndromes | Research centers | Malalties cardiovasculars | Bypass cardiopulmonar | Medicaments | Bypass cardiopulmonary | Plaquetes sanguínies | Cardiovascular diseases | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Apolipoproteins | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
by Hernandez, Adrian F and Green, Fiona and Green, Jennifer B and Janmohamed, Salim and D'Agostino, Ralph B and Granger, Christopher B and Jones, Michael and Jones, Nigel P and Leiter, Lawrence A and Rosenberg, Anne E and Rosenberg, Anne and Sigmon, Kristina and Sigmon, Kristina N and Somerville, Matthew and Somerville, Matthew C and Thorpe, Karl and Thorpe, Karl M and McMurray, John J V and McMurray, John J.V and Del Prato, Stefano and Califf, Robert M and Holman, Rury and DeMets, David and Riddle, Matthew and Goodman, Shaun and McGuire, Darren and Alexander, Karen and Devore, Adam and Melloni, Chiara and Patel, Chetan and Patel, Rajesh and Patel, Vickas and Patel, Prashant and Patel, Rajivkumar and Kong, David and Bloomfield, Gerald and Roe, Matthew and Tricoci, Pierluigi and Harrison, Rob and Harrison, Lindsay and Lopes, Renato and Mathews, Robin and Mehta, Anand and Mehta, Rajendra and Schuyler Jones, William and Vemulapalli, Sreekanth and Povsic, Thomas and Eapen, Zubin and Dombrowski, Keith and Kolls, Brad and Jordan, Dedrick and Ambrosy, Andrew and Greene, Deb and Greene, Stephen and Mandawat, Aditya and Shavadia, Jay and Cooper, John and Cooper, Lauren and Sharma, Abhinav and Sharma, Richa and Guimaraes, Patricia and Friedman, Daniel and Wilson, Matt and Wilson, Tim and Endsley, Patricia and Gentry, Tracy and Collier, Jeannie and Perez, Kathleen and James, Kourtnei and James, Rachel and Roush, Jennifer and Pope, Connie and Howell, Christina and Johnson, Megan and Johnson, David and Johnson, Andrew and Bailey, Matt and Cole, Joanna and Akers, Teresa and Vandyne, Beth and Thomas, Betsy and Rich, Jenny and Bartone, Susan and Beaulieu, Gail and Brown, Judith and Brown, Kim and Chau, Tuan and Christian, Tamra and Coker, Rebecca and Haddock, Trevorlyn and Jenkins, Wendy and Haque, Ghazala and Marquess, Marsha and Pesarchick, Jean and Rethaford, Renee and Stone, Allegra and Al Kawas, Firas and Anderson, Michelle and Enns, Robert and Sinay, Isaac and ... and Harmony Outcomes Comm Investigator and Harmony Outcomes committees and investigators
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Journal Article